BTIG Reiterates Buy on Neuronetics, Maintains $6 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 86.8%

Neg 0% Neu 86.8% Pos 0%

BTIG analyst Sam Eiber reiterates Neuronetics (NASDAQ:STIM) with a Buy and maintains $6 price target.

Comments

No comments yet. Be the first!